Stay updated on APL-501 with APL-101 in HCC and RCC Clinical Trial
Sign up to get notified when there's something new on the APL-501 with APL-101 in HCC and RCC Clinical Trial page.

Latest updates to the APL-501 with APL-101 in HCC and RCC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe web page has been updated to reflect a new version of the study, including the addition of the study's name 'Hepatocellular Carcinoma' and the collaborators involved, Apollomics Inc. and Novotech. The detailed study design and investigational plan have been removed, indicating a shift in focus or a simplification of the content.SummaryDifference35%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check88 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to APL-501 with APL-101 in HCC and RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APL-501 with APL-101 in HCC and RCC Clinical Trial page.